- decreased circulating glycerol level / IMPC
- decreased hemoglobin content / IMPC
- abnormal humerus morphology / IMPC
- decreased total body fat amount / IMPC
- increased lean body mass / IMPC
- decreased leukocyte cell number / IMPC
- decreased hematocrit / IMPC
- increased circulating amylase level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased erythrocyte cell number / IMPC
- improved glucose tolerance / IMPC
C57BL/6N-Atm1Brd Cibar1tm1a(KOMP)Wtsi/WtsiOrl
Status | Available to order |
EMMA ID | EM:09577 |
International strain name | C57BL/6N-Atm1Brd Cibar1tm1a(KOMP)Wtsi/WtsiOrl |
Alternative name | EPD0804_2_A04 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Cibar1tm1a(KOMP)Wtsi |
Gene/Transgene symbol | Cibar1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0804_2_A04. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous C57BL/6NTac |
Disease and phenotype information
IMPC phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).